NCT03485885

Bioavailability of Maqui Berry Extract (MBE) in Healthy Subjects

Bioavailability of Maqui Berry Extracts (Delphinol® / MaquiBright®) in Healthy Subjects

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 12 (actual)
• Sponsor: Anklam Extrakt · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The aim of the present study is to describe the bioavailability for the proprietary standardized maqui berry extracts Delphinol® and MaquiBright® enriched in anthocyanins and in particular delphinidins. The analyses are based on two selected key substances namely delphinidin-3-glucoside and cyanidin-3-sambubioside and their metabolism to phenolic acids. The bioavailability of anthocyanins specific for Delphinol®/MaquiBright® was analyzed in plasma sample kinetics (at 0h, 0.5h, 1h, 1.5h, 2h, 3h, 4h, 6h and 8h after intake of 1000mg standardized maqui berry extract in capsules) in 12 healthy subjects.

Conditions

• Bioavailability

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Standardized maqui berry extract enriched in anthocyanins	Single oral intake of 1000mg standardized maqui berry extract (in 4 capsules - 250mg each) with 200ml still water

Timeline

• Start date: 2017-11-23
• Primary completion: 2017-12-12
• Completion: 2017-12-12
• First posted: 2018-04-03
• Last updated: 2019-01-10

Locations

1 site across 1 country: Germany